Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.96M Buy
19,781
+603
+3% +$215K 0.74% 54
2025
Q4
$6.28M Buy
19,178
+162
+0.9% +$51.4K 0.69% 60
2025
Q3
$5.37M Buy
19,016
+829
+5% +$240K 0.61% 72
2025
Q2
$5.08M Sell
18,187
-1,396
-7% -$395K 0.62% 72
2025
Q1
$6.1M Buy
19,583
+395
+2% +$117K 0.8% 44
2024
Q4
$5M Buy
19,188
+15,368
+402% +$4.56M 0.69% 61
2024
Q3
$1.24M Sell
3,820
-68
-2% -$22.2K 0.45% 82
2024
Q2
$1.21M Sell
3,888
-33
-0.8% -$9.7K 0.47% 77
2024
Q1
$1.11M Sell
3,921
-185
-5% -$54.1K 0.42% 83
2023
Q4
$1.21M Buy
4,106
+100
+2% +$27.2K 0.48% 75
2023
Q3
$1.08M Sell
4,006
-79
-2% -$19.7K 0.45% 76
2023
Q2
$920K Buy
4,085
+733
+22% +$170K 0.37% 83
2023
Q1
$812K Buy
3,352
+122
+4% +$29.9K 0.3% 94
2022
Q4
$848K Buy
3,230
+83
+3% +$22.2K 0.33% 95
2022
Q3
$709K Sell
3,147
-27
-0.9% -$6.54K 0.29% 102
2022
Q2
$772K Buy
3,174
+2,054
+183% +$503K 0.29% 97
2022
Q1
$271K Buy
1,120
+18
+2% +$4.14K 0.09% 150
2021
Q4
$248K Sell
1,102
-83
-7% -$17.5K 0.08% 157
2021
Q3
$252K Sell
1,185
-19
-2% -$4.37K 0.08% 148
2021
Q2
$293K Buy
1,204
+1
+0.1% +$246 0.09% 145
2021
Q1
$299K Sell
1,203
-128
-10% -$30.5K 0.09% 150
2020
Q4
$306K Sell
1,331
-194
-13% -$44.7K 0.09% 139
2020
Q3
$388K Sell
1,525
-281
-16% -$69.6K 0.12% 121
2020
Q2
$426K Sell
1,806
-239
-12% -$54.5K 0.12% 101
2020
Q1
$415K Sell
2,045
-127
-6% -$27.7K 0.12% 121
2019
Q4
$524K Sell
2,172
-147
-6% -$32.4K 0.12% 127
2019
Q3
$449K Sell
2,319
-562
-20% -$108K 0.11% 109
2019
Q2
$531K Buy
2,881
+1
+0% +$179 0.11% 108
2019
Q1
$547K Sell
2,880
-106
-4% -$20.2K 0.12% 100
2018
Q4
$581K Sell
2,986
-132
-4% -$25.8K 0.13% 91
2018
Q3
$646K Buy
3,118
+129
+4% +$25.4K 0.16% 91
2018
Q2
$552K Sell
2,989
-80
-3% -$14.2K 0.14% 87
2018
Q1
$523K Sell
3,069
-97
-3% -$17.8K 0.14% 86
2017
Q4
$551K Buy
+3,166
New +$560K 0.17% 78

Other funds holding AMGN

Columbus Macro's AMGN Position: Q1 2026 in Review

Columbus Macro increased its Amgen (AMGN) stake by 3.1% in Q1 2026, buying an estimated $215K and bringing the position to 19,781 shares worth $6.96M. The position accounts for 0.74% of the portfolio, ranked #54.

Columbus Macro first reported a position in AMGN in Q4 2017 and has held it in 34 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Columbus Macro held 19,781 shares of Amgen worth $6.96M as of Q1 2026.
  • Columbus Macro bought 603 Amgen shares in Q1 2026, an estimated $215K.
  • Amgen made up 0.74% of Columbus Macro's portfolio in Q1 2026, its #54 holding.
  • Columbus Macro first reported a position in Amgen in Q4 2017 and has held it in 34 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Columbus Macro's 13F filing for Q1 2026, filed 21 Apr 2026.